About this trial

This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.

Eligibility criteria

Qualifiers

Adult >18 years old and able to consent

Capable of using a smartphone app

Willing to shave patch area if needed

Disqualifiers

Planning to undergo an MRI during the study period

Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results

Presence of pacemaker, ICD or other implanted electronic devices

Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum)

Trial design

Treatments tested in this trial

  • eWave Patch

Treatment groups

500 Participants
are divided into 2 treatment groups

Locations

1
ABio Clinical Research Partners28127, New LondonNorth Carolina, United States

Sponsors and collaborators

Wearlinq

Lead sponsor

ABio Clinical Research Partners

Collaborator